Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 : vimarsana.com

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ...

Related Keywords

Amsterdam , Noord Holland , Netherlands , American Samoa , Italy , Canada , France , United States , United Kingdom , South Africa , Japan , London , City Of , America , Italian , Van Lanschot Kempen , Michael Levitan , Exchange Commission , Company Euronext Amsterdam , Pharming Groupnv , Nasdaq , Vp Investor Relations Corporate Communications , Linkedin , Lifespring Life Sciences Communication , Bonds , Pharming Group , Euronext Amsterdam , Eligible Bondholders , Securities Act , Joint Dealer Managers , North America , Middle East , Annual Report , Spring Life Sciences Communication , Markets ,